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Article Information Abstract
Injectable DMPA contraception can cause changes in lipoprotein metabo-
lism. Changes in fat metabolism occur because of the hormonal influence of
progesterone, causing disruption of the balance of lipid profiles in the body.
The change in serum lipid profile (trgliseride, total cholesterol, HDL and
LDL) in long-term use of DMPA is a risk factor for atherosclerosis and car-
diovascular disease. The purpose of this study was to look at the descrip-
tion of the lipid profile at 3 months injection acceptors. The design of the
study was descriptive. The population in this study was 76, the number of
samples that met the inclusion and exclusion criteria in this study was 30.
Examination of the lipid profile was carried out with an enzymatic colorimet-
ric (cholesterol oxidase method / CHOD PAP). The results of lipid profile
examination showed that 13.33% had high cholesterol levels, 3.33% had
high triglyceride levels, 13.33% had high HDL levels, 20% had high LDL
levels and 3.33% have very high LDL levels. The conclusion of this study
was long term use of DMPA injection contraception could cause changes in
the lipid profile, so it is recommended for acceptors who want to use contra-
ception in the long term to use MKJP as an option so as not to affect the fat
profile in the body.
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INTRODUCTION
The family planning program (KB) is an effort
to regulate birth spacing, determine the ideal
distance and age to prepare for childbirth, regulate
pregnancy spacing, through promotional activities,
care and assistance in accordance with reproductive
rights in order to create a quality family (PP RI No.
87 Year 2014). The targets in implementing the
family planning program are fertile age couples
(PUS). What is called Fertile Age Couples (PUS)
is a husband and wife whose wife is between 15
and 49 years old (BKKBN, 2011).
The number of active FP participants in 2017
was 63.22%, while those who never used FP was
18.63%. Based on the pattern in choosing the type
of contraception, the majority of active contra-
ceptives chose injections and pills as contraceptives,
even more dominant (more than 80%) compared
to other methods; injections (62.77%) and pills
(17.24%) (Kemenkes RI, 2018).
According to data from the Family Health
Section, the number of couples of childbearing ages
in the Jember Regency area in 2016 was recorded
at 411,230 people. Of the total PUS, the coverage
of new family planning participants was 38,114 or
9.3% and active family planning participants
reached 353,403 people (85.9%). While the
coverage of family planning participants according
to the type / contraceptive used in 2016, the highest
percentage of contraceptive use by participants was
injection contraceptive at 51.6% and the least used
contraceptives were MOP (1.1%), vaginal medicine
(1,1%) and MOW (1.2%) (DINKES, 2017).
DMPA (Depot Medroxy Progesterone
Asetate) injectable contraceptives can cause
changes in lipoprotein metabolism, an increase in
body mass can occur due to different fat profiles
under normal conditions. DMPA (Depot Medroxy
Progesterone Asetate) will increase serum fat so
that it will have an impact on weight gain (Bakry
and Abdullah, 2008). Similar study also shows the
same thing, namely study on the effect of using
hormonal contraception on weight gain shows that
injection contraceptive use significantly increases
the risk of weight gain (Yuniastuti, 2011).
To improve family planning and reproductive
health services, the government established a
PKBPK (Population, Family Planning & Deve-
lopment Program) program.with the target of
implementing the Population, Family Planning and
Family Development programs at all regional levels.
Population and family planning development policies
and strategies can be pursued by improving access
and quality of family planning services that are
evenly distributed in every region and community
group and through 8 Population Development and
Family Planning strategies. One of the 8 strategies
states that improving family planning services is
carried out by using MKJP to reduce the risk of
drop-out and use of non-MKJP by providing
continuous information for the sustainability of family
planning participation and with indicators of
increasing use of MKJP. (HOGSI, 2018)
Yadav (2011), in his study on the effect of long-
term use of DMPA on lipid metabolism in 60 women
in Nepal who had used it for more than 2 years
showed that the levels of triglycerides, total
cholesterol and Low Densities Lipoprotein (LDL)
were higher than non-acceptors, while the levels of
High Densities Lipoprotein (HDL) decreased.
Because of this, it can be concluded that DMPA
can cause changes in lipid metabolism which can
increase the risk of cardiovascular disease (heart
disease). Changes in fat metabolism occur due to
the influence of the hormonal progesterone, which
causes disruption of the balance of the lipid profile
in the body.
Changes in serum lipid profiles (triglycerides,
total cholesterol, HDL and LDL) on long-term use
of DMPA are a risk factor for atherosclerosis (fat
accumulation in the artery walls) and cardiovascular
disease. Increased levels of triglycerides, total
cholesterol, LDL and decreased HDL and increased
excess body weight are the diagnostic criteria for
metabolic syndrome that can increase the incidence
of type II and cardiovascular diabetes mellitus.
Therefore, lipid profile is the best predictor of
metabolic syndrome.
From a preliminary study that has been
conducted by studyers of 10 3 months injection
family planning acceptors, 7 of them used injectable
contraception for 3 months for more than 3 years.
Therefore, studyers are interested in knowing the
description of the lipid profile of injection users with
DMPA (Depo Medroxy Progeserone Acetate) in
the working area of   the Banjar Sengon Community
Health Center, Jember Regency.
METHODS
This type of study was a quantitative
descriptive study. The analysis used distribution,
frequency and percentage. The variable was the
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Based on Table 1, it can be seen that there are
6 respondents (20%) who accept DMPA injection
with a duration of use <1 year, 9 respondents (30%)
who use 1-3 years (30%) and those using> 3 years
are 15 respondents (50%).
Based on Table 2, it can be seen that the 3
months injection family planning acceptors who
have cholesterol levels within the high limit are as
many as 4 respondents (13.33%), there is 1
respondent (3.33%) who has triglyceride levels in
the high limit category, while for levels There are 9
HDL respondents (30%) who have low HDL
categories and 4 respondents (13.33) who have high
HDL categories, for LDL levels that have been
checked there are 14 respondents (46.6%) with
LDL levels near optimal, 6 respondents (20%) had
high LDL levels and 1 respondent (3.33) had high
LDL categories.
DISCUSSION
Most of the respondents in this study were
acceptors of 3-month injection with a duration of
more than 3 years of use, as much as 50%. Several
description of the lipid profile of users who inject
DMPA (Depo Medroxy Progeserone Acetate). The
population in this study was all 3 months injection
family planning (DMPA) acceptors at Integrated
Healthcare Center Alamanda, Jumerto Village in
the working area of the Banjar Sengon Health
Center, Jember Regency. The number of samples
that met the inclusion and exclusion criteria was 30
respondents.
Prior to conducting the study, this study has
received approval from the ethical clearance of
STIKES dr. Soebandi Jember. The data collection
process was carried out by taking a sample of the
respondent’s blood and then measuring the lipid
profile using the enzymatic colorimetric method
(CHOD PAP).
RESULT
No. Duration of KB usage amount Frequency (%)
1 <1 year 6 20
2 1-3 Years 9 30
3 > 3 Years 15 50
amount 30 100
Table 1 Frequency Distribution of Duration of Use of
3-Month Injectable KB (DMPA)
No. Checking type amount Frequency (%)
1 CHOLESTEROL
Desired < 200 26 86.67
High Limit (200-239) 4 13.33
Height > 239 0 0.00
2 TRIGLICERIDE
Normal < 150 29 96.67
High Limit (150-199) 1 3.33
High (200-499) 0 0.00
Very High > 500 0 0.00
3 HDL
Low < 40 9 30.00
Height > 60 4 13.33
Normal 17 56.67
4 LDL
Optimal < 100 9 30.00
Approaching Optimal
(100-129) 14 46.67
High limit (130-159) 6 20.00
High (160-189) 1 3.33
Very high > 500 0 0
amount 30 100
Table 2 Lipid Profiles of 3-month injection family plan-
ning (DMPA) acceptors
studies have reported a decrease in total cholesterol
(TC), triglyceride (TG), and low-density lipoprotein
(LDL-C) cholesterol in DMPA users (Yadav, 2011).
According to (Dilshad et al., 2016) the side effects
of excessive progesterone content in the cardio-
vascular system can cause changes in cholesterol
levels. Changes in cholesterol levels will increase
with age, duration of use of contraception and weight
gain. According to studyers, cholesterol levels in
respondents varied due to differences in the length
of time using contraception.
Of the 30 respondents, there were 4
respondents (13.33%) who had cholesterol levels
within the high limit. The results of this study are in
accordance with the results of study conducted by
Wulandari (2019) which states that the longer use
of injectable contraceptives for 3 months indicates
a tendency for cholesterol levels to be above normal.
Most of 12 respondents (48%) had normal
cholesterol levels and 7 respondents (28%) had
cholesterol levels that were above normal for 3
months for 3 months for 3-6 years. While the
duration of use of contraception with a usage period
of  6 years, as many as 6 respondents (24%) had
cholesterol levels above normal.
46 Jurnal Ners dan Kebidanan, Volume 8, Issue 1, April 2021, page 43–48
Long-term and regular use of injectable
contraceptives for 3 months can result in the
accumulation and influence of the accumulation of
these hormones which can cause fat metabolism to
increase (Utami, 2015). One of the disadvantages
of using DMPA injection contraceptive is that there
is a change in serum lipids where cholesterol levels
increase in long-term use (Saifuddin, 2006).
In addition to an increase in cholesterol levels,
there was 1 respondent (3.33%) who had
triglyceride levels in the high limit category. The
results of this study are in accordance with the
results of study conducted by Hartiti (2010) which
states that the longer the use of DPMA Injectable
KB, the higher the water content in the blood as
indicated by the increase in body weight and the
longer using DPMA Injectable KB the fat levels in
the blood are also increased which is indicated by
increased levels of triglycerides in the blood.
Triglycerides play a role in risk factors for
atherosclerosis and coronary heart disease (CHD)
when accompanied by decreased HDL levels.
A similar study was also conducted by Sanger,
et al (2008) regarding the effect of DMPA on the
lipid profile showing that triglyceride levels
decreased at 1 month after giving DMPA but not
Significantly, after 3 months of DMPA adminis-
tration there was a significant decrease in trigly-
ceride levels and at 6, 9, 12 months the triglyceride
levels increased again but it was not statistically
significant. In this study, the results showed an
average increase in triglyceride levels at 6 months
after DMPA administration (94.60 mg / dl).
So, the studyers concluded that the possible
increase in triglyceride levels in this study was also
due to the use of 3 months injection contraception
for a long period of time. To anticipate some
problems related to the side effects of long-term
use of DMPA, especially those related to the lipid
profile, respondents should be advised to use long-
term contraceptive methods as an alternative to
delaying pregnancy and routine lipid profile checks
on all DMPA acceptors of contraception in the long
term are necessary. .
Many experts argue that the use of DMPA does
not cause changes in lipid metabolism, but in fact
many studies have found changes in serum lipid
profiles (total cholesterol, HDL, LDL, triglycerides)
in long-term use of DMPA (Sanger, 2008). In this
study also found changes in HDL and LDL in the
respondents who had been sampled.
For HDL levels, it was found that 9 respondents
(30%) had low HDL categories and 4 respondents
(13.33) who had high HDL categories, while 14
respondents (46.6%) had LDL levels with high HDL
levels. category close to optimal, 6 respondents
(20%) who had high LDL levels and 1 respondent
(3.33) had high LDL categories.
Based on study conducted by Bakry (2009),
he examined DMPA acceptors, before contra-
ceptive use and after 1, 6, 7, 12 and 13 months of
use, it was found that progestins can induce a
decrease in all lipid components by about 30% and
tend to increase Low Density Lipoproteins. (LDL),
and reduce High Density Lipoprotein (HDL) by
about 15%. These findings may indicate a
disadvantage for long-term 3-month injection family
planning (DMPA) acceptors.
According to the theory the effect of
glucocorticoids on DMPA is to increase lipolysis.
Lipolysis (hydrolysis) is the process of breaking
down triglycerides through diacylglycerols into
monoacylglycerols and finally to free fatty acids and
glycerol. Furthermore, large amounts of free fatty
acids are carried to the liver, thereby increasing
hepatic triglyceride synthesis and increasing the
secretion of Very Low Densities Lipoprotein
(VLDL) by the liver. In a state of insulin resistance,
VLDL increases in the circulation and will increase
LDL because most of the LDL is formed from
VLDL (Botham, KM and Mayes, 2009).
The results of study from Fransisca (2020)
stated that the LDL level in the DMPA acceptor
with a duration of use of more than 3 years was
higher than that of the depo medroxyprogesterone
acetate acceptor with a duration of use less than 3
years. Although it is not statistically significant.
The more LDL in the plasma, the less HDL
levels.HDL functions to transport free cholesterol
from blood vessels and other tissues to the liver
and then the liver excretes it through bile so it is
also known as cleaning cells. So, it can be concluded
that the more LDL increases, the more HDL it
clears the cholesterol carried by LDL, causing a
decrease in HDL levels in the blood (Botham, KM
and Mayes, 2009).
A decrease in HDL levels in the blood
accompanied by an increase in LDL levels can
cause dyslipidemia. Dyslipidemia is a condition that
occurs when the levels of fat in the bloodstream
are too high or too low and dyslipidemia is a risk
factor for the development of atherosclerosis.
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Atherosclerosis will result in blockage and
accumulation of fat or blood clots (Gde Ary Putra
Kamajaya, AA Wiradewi Lestari, 2016).
This study was conducted at the time of the
Covid 19 pandemic, so there is a limitation in this
study, which is the minimum number of samples
because some respondents refused to become
samples due to the Covid 19 pandemic and The
location of the study was moved to one of the
Integrated Healthcare Center which was initially
carried out in 1 village due to PSBB conditions and
an increase in the number of Covid 19 cases in the
Jember district, the Public Health Center limited or
minimized contact with patients to minimize the
presence of Covid 19 transmission by narrowing
the study area.
CONCLUSION
From the results of this study, it was found that
4 months of injection family planning acceptors who
had cholesterol levels in the high limit were 4
respondents (13.33%), 1 respondent (3.33%) had
triglyceride levels in the high limit category, while
HDL levels contained 9 respondents (30%) who
have low HDL category and 4 respondents (13.33)
who have high HDL category, for LDL levels that
have been checked there are 14 respondents
(46.6%) with LDL levels near optimal,  6
respondents (20%) had high LDL levels and 1
respondent (3.33) had high LDL categories.
 The variations in the results of examining the
lipid profile in this study were influenced by various
factors, one of which was the use of 3 months
injection contraceptives for a long period of time.
SUGGESTION
To anticipate some problems related to the side
effects of long-term use of DMPA, especially
related to the lipid profile, it is better if the related
health facilities provide facilities for providing MKJP
for respondents and encourage respondents to use
long-term contraceptive methods as an alternative
to delaying pregnancy and need to do profile checks
lipids routinely against all long-term DMPA
contraceptive acceptors.
Suggestions for further study are to conduct
study on a similar topic with a larger number of
samples and provide therapy to overcome changes
in lipid profiles as a preventive measure for health
workers.
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